en

PRODUCT DETAIL

Azacitidine Kabi 25 mg/ml prášok na injekčnú suspenziu

Code 5269E
MA number EU/1/23/1777/001
Product Form: plv inu 1x100 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BC Pyrimidine analogues
L01BC07 Azacitidine
Shelf life: 24
Container: glass vial
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 05.01.2024
Validity: 05.01.2029
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 19.01.2024
eu-flag.png sk-flag.png